Therapeutic Programs
Internal Preclinical Development
Our platform solution for improving ADCs with Super-ADCs enables us to explore multiple indications simultaneously to ensure that only our best development candidates enter the clinic. Our internal programs leverage Super-ADCs against targets that are backed by clinical validation, but where ADCs have fallen short in delivering promising results.
Partner With Us
Our approach has the potential to improve the therapeutic index of existing assets, to unlock novel targets with low internalization, and to enable lower potency payloads to be effective in the ADC field. We aim to leverage Super-ADCs in co-development partnerships to broadly propel ADCs toward first line therapy by dramatically impacting their safety profile.
Contact Us
